← Back to Clinical Trials
Recruiting NCT06489262

NCT06489262 Efficacy Trial of Healthy Together ("Juntos")

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06489262
Status Recruiting
Phase
Sponsor University of Miami
Condition Obesity
Study Type INTERVENTIONAL
Enrollment 750 participants
Start Date 2025-02-28
Primary Completion 2029-05-31

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
Healthy Together ("Juntos")

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 750 participants in total. It began in 2025-02-28 with a primary completion date of 2029-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to assess the efficacy of a family-based digital (web and mobile phone-based) program known as Healthy Together ("Juntos") in preventing increases in body mass index and improving moderate-to-vigorous physical activity, diet quality, and percentage body fat among Hispanic adolescents.

Eligibility Criteria

Inclusion Criteria: Adolescent 1. Lives with participating biological parent or legal guardian; 2. Self-identifies as Hispanic; 3. Is between the ages of 12-15years old; 4. Has access to a smartphone; 5. Does not meet recommendations for physical activity as determined by a validated 2-item screener; 6. Does not meet recommendations for daily fruit and vegetable intake (proxy for diet quality) as determined by a validated 2-item screener; 7. Exceeds recommendations for screen time (proxy for sedentary behavior) as determined by a validated 6-item screener Parent 1. Is the biological parent or legal guardian of and lives with the adolescent; 2. Self-identifies as Hispanic; 3. Has access to a smartphone; Exclusion Criteria: Adolescent 1. Has BMI \<5th (underweight) or ≥95th percentile (obesity); 2. Has a parent-reported chronic medical condition (e.g., type 2 diabetes) that requires more intensive intervention; 3. Has parent-reported responses on a physical activity readiness questionnaire (PAR-Q) that indicates a serious health issue, and a physician does not approve participation; 4. Has a parent-reported cognitive or developmental delay (e.g., Down Syndrome) that may interfere with understanding program materials. Parent 1. Provides PAR-Q responses that indicate a serious health issue and a physician does not approve participation; 2. Reports family plans to move out of South Florida during the study follow-up period

Contact & Investigator

Central Contact

Sara St George, PhD

✉ healthyjuntos@med.miami.edu

📞 1 (305) 243-0726

Principal Investigator

Sara St George, PhD

PRINCIPAL INVESTIGATOR

University of Miami

Frequently Asked Questions

Who can join the NCT06489262 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 15 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06489262 currently recruiting?

Yes, NCT06489262 is actively recruiting participants. Contact the research team at healthyjuntos@med.miami.edu for enrollment information.

Where is the NCT06489262 trial being conducted?

This trial is being conducted at Miami, United States.

Who is sponsoring the NCT06489262 clinical trial?

NCT06489262 is sponsored by University of Miami. The principal investigator is Sara St George, PhD at University of Miami. The trial plans to enroll 750 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology